Aquestive Therapeutics, Inc.

US$3.61As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AQSTHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (15.84%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.50
PE TTM —
TSR TTM (47.07%)
Mkt cap US$453.7M
ROIC (276.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.45
(4.51%)
(42.05%)
Sell 0|9|6|0|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.06
0.06
17.79%
22.48%
22.72%
21.65%
Revenue$M
33.41
35.13
34.20
33.70
2.46%
5.57%
0.88%
1.58%
Peers (US$453.7M)
Cap (US$)
PE
450.4M
—
450.8M
38.23x
Capital
TTM
5Y
10Y
Leveragex
0.915
(0.046)
(0.038)
EBIT/Intx
2.039
1.576
1.221
Own earn%
29.10
238.45
287.66
Sh yield%
32.25
2.97
6.53
Owners
Insiders/Inst%
0.12
63.26
Short interest%
1.43
SBC / revenue%
1.43
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
13